Search BRITE hierarchies

Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
  R RESPIRATORY SYSTEM
    R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
      R03A ADRENERGICS, INHALANTS
        R03AC Selective beta-2-adrenoreceptor agonists
          R03AC19 Olodaterol [DG:DG01058]
            D10020  Olodaterol hydrochloride (JAN/USAN) <US>

USP drug classification [BR:br08302]
  Respiratory Tract/Pulmonary Agents
    Bronchodilators, Sympathomimetic
      Olodaterol [DG:DG01058]
        D10020  Olodaterol hydrochloride (JAN/USAN)

Drug groups [BR:br08330]
  Cardiovascular agent
    DG01456  Adrenergic receptor agonist
      DG01455  beta-Adrenergic receptor agonist
        DG01452  beta2-Adrenergic receptor agonist
          DG01058  Olodaterol
            D10020  Olodaterol hydrochloride
  Metabolizing enzyme substrate
    DG02918  CYP2C8 substrate
      DG01058  Olodaterol
        D10020  Olodaterol hydrochloride
    DG01642  CYP2C9 substrate
      DG01058  Olodaterol
        D10020  Olodaterol hydrochloride
    DG02924  UGT substrate
      DG03183  UGT1A1 substrate
        DG01058  Olodaterol
          D10020  Olodaterol hydrochloride
      DG03185  UGT1A7 substrate
        DG01058  Olodaterol
          D10020  Olodaterol hydrochloride
      DG03188  UGT1A9 substrate
        DG01058  Olodaterol
          D10020  Olodaterol hydrochloride
      DG03190  UGT2B7 substrate
        DG01058  Olodaterol
          D10020  Olodaterol hydrochloride

Target-based classification of drugs [BR:br08310]
  G Protein-coupled receptors
    Rhodopsin family
      Adrenaline
        ADRB2 [HSA:154] [KO:K04142]
          D10020  Olodaterol hydrochloride (JAN/USAN) <US>

New drug approvals in the USA [br08319.html]
  D10020

New drug approvals in the USA, Europe and Japan [br08328.html]
  D10020

Drug metabolizing enzymes and transporters [br08309.html]
  D10020

[ BRITE | KEGG2 | KEGG ]